Biography
Specialties
Pediatrics, Allergy and Immunology, Pediatric Allergy and Immunology
Pediatrics, Allergy and Immunology, Pediatric Allergy and Immunology
Julie Wang, MD
PROFESSOR | Pediatrics
PROFESSOR | Pediatrics
Are you a patient?
View my
Are you a patient?
View my
Biography
Specialties
Research
Dr. Wang's research focus on developing new treatments for food allergies and gaining a better understanding of how patients and their families manage food allergies. She is currently involved in clinical trials to assess the safety and efficacy of oral immunotherapy.
Education
MD, Weill Medical College of Cornell University
Residency, Pediatrics, New York Presbyterian Hospital-Weill Cornell Center
Fellowship, Allergy & Immunology, Mount Sinai Hospital
Certifications
American Board of Allergy & Immunology
American Board of Pediatrics
Publications
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Wang during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- ALK Abello
- Jubilant HollisterStier
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Wang during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- ALK Abello
- Jubilant HollisterStier
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.